Page:Healthcare Services Act 2020.pdf/53

Rh (4) A direction given under subsection (1) may relate to a clinical ethics committee appointed by a section 25 licensee, and require the licensee to require that committee to conduct a further ethics review of—
 * (a) any proposed prescribed medical treatment mentioned in section 26 for an individual; or
 * (b) any other clinical case for which an ethics review is requested by the Director, the section 25 licensee or the medical practitioner in charge of that clinical case.

(5) A direction mentioned in subsection (2)(b)(ii) or (3)(b)(ii) may require the section 25 licensee—
 * (a) to change any of the section 25 licensee’s procedures or practices in the provision of the licensable healthcare service; or
 * (b) to remove an individual from that individual’s appointment as the section 25 licensee’s Principal Officer or Clinical Governance Officer (as the case may be), and appoint another individual as Principal Officer or Clinical Governance Officer, as the case may be.

(6) Where the Director has reasonable grounds to believe that a quality assurance committee, service review committee or clinical ethics committee appointed by a section 25 licensee is not performing any function or discharging any duty under this Act in a proper or satisfactory manner, the Director may direct the section 25 licensee—
 * (a) to remove or replace any member of that committee;
 * (b) to appoint one or more additional members to that committee; or
 * (c) to dissolve that committee and appoint another such committee in its place.